title: Reality of pediatric cancer in Iraq.
abstract: This brief report displays comprehensive details of health services provided by Children's Welfare Teaching Hospital, medical city, Baghdad. In 2010; 366 children with newly diagnosed cancer were admitted for treatment, two thirds were leukemia and lymphoma cases followed by other solid tumors except brain tumors. With this large number of patients; there are shortcomings in provision of health services in many aspects including professional manpower, infrastructure, diagnostic and therapeutic facilities, supportive and palliative care. The previous wars and sanction and the current instability of the country added to the socioeconomic difficulties of the families jeopardizing the appropriate therapy and ultimately the poor treatment outcome. Since 2003 an international collaboration had a major contribution in many aspects like provision of drugs and medical supplies, attendance of scientific workshops, and updating doctor's knowledge and experience through telemedicine programs which resulted in decreasing the induction mortality in acute lymphoblastic leukemia from 24% in the year 2007% to 10% in 2010 after introduction of pre-phase steroids and in acute promyelocytic leukemia from 95% to 5% after introduction of all trans-retinoic acid. A collaborative work with Rome University resulted in changing diagnosis of 20% of pathological samples sent there for reevaluation. Iraqi pediatric oncologists still need real attempts to improve infrastructure and human resources in addition to twinning programs with internationally recognized cancer centers to face these management challenges.
authors.affiliation: Oncology Unit, Department of Pediatrics, Children Welfare Teaching Hospital, Baghdad College of Medicine, Baghdad, Iraq. cancer@mecc-research.com
authors.forename: Salma Abbass
authors.initials: SA
authors.lastname: Al-Hadad
authors.forename: Mazin Faisal
authors.initials: MF
authors.lastname: Al-Jadiry
authors.forename: Amir Fadhil
authors.initials: AF
authors.lastname: Al-Darraji
authors.forename: Raghad Majid
authors.initials: RM
authors.lastname: Al-Saeed
authors.forename: Safaa Faraj
authors.initials: SF
authors.lastname: Al-Badr
authors.forename: Hasanein Habeeb
authors.initials: HH
authors.lastname: Ghali
mesh_terms: D001859:Bone Neoplasms / Q000401:mortality / Q000628:therapy; D002648:Child; D003695:Delivery of Health Care / Q000458:organization & administration / Q000706:statistics & numerical data / Q000639:trends*; D019337:Hematologic Neoplasms / Q000401:mortality / Q000628:therapy; D006801:Humans; D007493:Iraq / Q000453:epidemiology; D007680:Kidney Neoplasms / Q000401:mortality / Q000628:therapy; D008495:Medical Oncology / Q000458:organization & administration / Q000706:statistics & numerical data / Q000639:trends*; D009369:Neoplasms / Q000401:mortality* / Q000628:therapy*; D010372:Pediatrics / Q000458:organization & administration / Q000706:statistics & numerical data / Q000639:trends*; D019572:Retinal Neoplasms / Q000401:mortality / Q000628:therapy; D012175:Retinoblastoma / Q000401:mortality / Q000628:therapy; D009396:Wilms Tumor / Q000401:mortality / Q000628:therapy